What is the anticipated absolute effect of prescribed ACE-I at target dose for patients with chronic heart failure?
The anticipated absolute effect of prescribed ACE-I at target dose for patients with chronic heart failure is 574 ACE-I per 1000, with a risk difference of 92 fewer ACE-I per 1000 (from 224 fewer to 97 more) according to the NICE 2018 Clinical Evidence Summary.